Outcomes after Transplant in Relapsed/Refractory KMT2Ar (MLLr)and mNPM1 (NPM1c)leukemia Patients Achieving Remissions after Menin Inhibition: SNDX-5613 (revumenib) Ph1 Experience
| Autor: | Issa, Ghayas C., Cuglievan, Branko, Stein, Eytan, Arellano, Martha L., Žucenka, Andrius, Khera, Nandita, Stone, Richard M., Thirman, Michael J., DiPersio, John F., Karras, Nicole, Gu, Yu, Bagley, Rebecca G., Rosen, Galit, Tamang, David, Dishman, Kimberly, Scalera, Sushama, Meyers, Michael L., Madigan, Kate, McNeer, Nicole, Aldoss, Ibrahim |
|---|---|
| Zdroj: | Blood; November 2022, Vol. 140 Issue: 1, Number 1 Supplement 1 p914-916, 3p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|